One unlikely survivor from the TGN1412 drug trial may lose body parts:
Wilson had slipped into a coma for three weeks after taking the drug, and after awakening, discovered that he may lose parts of his fingers and toes, which had turned black because of his reaction to the drug.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
